Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 365

1.
2.

99mTc-MAG3 kinetics in the normal pig. A comparison to 131I-OIH and 125I-iothalamate after single injection and during continuous infusion.

Rehling M, Fr√łkiaer J, Poulsen EU, Marqversen J, Nielsen BV, Bacher T.

Clin Physiol. 1995 Jan;15(1):57-71.

PMID:
7712693
3.

Clearance and renal extraction of technetium-99m-L,L-ethylenedicysteine, I-131-ortho-iodohippurate and I-125-iothalamate in pigs.

Nielsen SS, Poulsen EU, Marqversen J, Nielsen LE, Bacher T, Rehling M.

Clin Physiol. 1999 Jul;19(4):338-43.

PMID:
10451795
4.

Reproducibility of 99Tcm-MAG3 clearance in normal volunteers with the two-sample method: comparison with 131I-OIH.

Kanazawa T, Shimizu M, Seto H, Kageyama M, Kameda K, Toyoshima S, Tomizawa G, Watanabe N, Inagaki S.

Nucl Med Commun. 1998 Sep;19(9):899-903.

PMID:
10581597
5.

Age-dependent enzymuria, proteinuria and changes in renal blood flow and glomerular filtration rate in rats.

Casadevall G, Piera C, Setoain J, Queralt J.

Mech Ageing Dev. 1995 Jul 28;82(1):51-60.

PMID:
7475356
6.

Comparison of 99mTc-mercaptoacetyltriglycine and [131I]-o-iodohippurate elimination in perfused rat kidney.

Trejtnar F, Laznicek M, Laznickova A.

Nucl Med Biol. 2003 Jan;30(1):45-9.

PMID:
12493542
7.
10.

Renal and extrarenal clearance of 99mTc-MAG3: a comparison with 125I-OIH and 51Cr-EDTA in patients representing all levels of glomerular filtration rate.

Rehling M, Nielsen BV, Pedersen EB, Nielsen LE, Hansen HE, Bacher T.

Eur J Nucl Med. 1995 Dec;22(12):1379-84.

PMID:
8586082
11.

Prediction of renal transplant survival from early postoperative radioisotope studies.

Russell CD, Yang H, Gaston RS, Hudson SL, Diethelm AG, Dubovsky EV.

J Nucl Med. 2000 Aug;41(8):1332-6.

12.

A comparison of prediction equations for estimating glomerular filtration rate in adults without kidney disease.

Lin J, Knight EL, Hogan ML, Singh AK.

J Am Soc Nephrol. 2003 Oct;14(10):2573-80. Erratum in: J Am Soc Nephrol. 2005 Sep;16(9):2814.

13.

Preliminary results comparing OIH, 99mTc-MAG3 and iothalamate in a rat model of renal ischemia.

Eshima D, Greene J, Taylor A Jr.

Contrib Nephrol. 1990;79:24-7. No abstract available.

PMID:
2146085
14.

How gender and age affect iodine-131-OIH and technetium-99m-MAG3 clearance.

Bagni B, Bagni I, Orsolon P, Corazzari T.

J Nucl Med Technol. 2000 Sep;28(3):156-8.

15.

99mTc-MAEC complexes: new renal radiopharmaceuticals combining characteristics of (99m)Tc-MAG3 and (99m)Tc-EC.

Taylor AT, Lipowska M, Hansen L, Malveaux E, Marzilli LG.

J Nucl Med. 2004 May;45(5):885-91.

17.

Evaluation of 99mTc-MAG3-annexin V: influence of the chelate on in vitro and in vivo properties in mice.

Vanderheyden JL, Liu G, He J, Patel B, Tait JF, Hnatowich DJ.

Nucl Med Biol. 2006 Jan;33(1):135-44.

PMID:
16459269
18.

Estimation of 99Tcm-MAG3 clearance using a single blood sample obtained over a continuous time interval.

Piera C, Ros D, Pavia J, Fuster D, Muxi A.

Nucl Med Commun. 1997 Jan;18(1):60-5.

PMID:
9061703
19.

Technetium-99m DTPA dimethyl ester: a renal function imaging agent. Comparative studies in animals with technetium-99m mercaptoacetyl triglycine and 131I-ortho-iodohippurate.

Bhowal K, Bhattacharyya S, Majumdar A, Giri C, Vanaja R, Ramamoorthy N, Ganguly S, Sarkar BR, Banerjee S, Chatterjee Debnath M.

Nucl Med Commun. 2003 May;24(5):583-95.

PMID:
12717078
20.

Evaluation of gamma camera-based measurement of individual kidney function using iodine-123 orthoiodohippurate.

Oriuchi N, Inoue T, Hayashi I, Mizuiri S, Kosaka N, Nishikawa J, Sasaki Y, Endo K.

Eur J Nucl Med. 1996 Apr;23(4):371-5.

PMID:
8612655

Supplemental Content

Support Center